Our airway research division is a highly specialized, academia-affiliated facility that focuses on early-phase and proof-of-concept trials. We have considerable experience in conducting clinical trials in respiratory indications such as asthma, allergic rhinitis, COPD, interstitial lung disease/diffuse parenchymal lung diseases, in particular idiopathic pulmonary fibrosis (IPF), sarcoidosis, and other ILDs.
The largest share of studies is devoted to asthma, COPD, and allergic rhinitis, many of them using the Fraunhofer Allergen Challenge Chambers (Fraunhofer ACCs). Normally we initiate 7-10 new studies of respiratory indications a year.
For full-service projects, we work with CROs that have extensive experience with respiratory indications.